EU agrees new Pfizer Covid vaccine deal and secures nearly half its annual output

The EU is doubling its purchases of the Pfizer-BioNTech coronavirus vaccine at a time of growing concern over its rollout.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.